Empagliflozin is prescribed for a patient with type 2 diabetes Mellitus. What is the most common side effect that the nurse should include in the patient's teaching plan?

A. Genitourinary infections: Empagliflozin, an SGLT2 inhibitor, increases glucose excretion in the urine, creating a favorable environment for bacterial and fungal growth. This leads to an increased risk of urinary tract infections and genital yeast infections. B. Pancreatitis: Pancreatitis is associated more with GLP-1 receptor agonists, such as exenatide or liraglutide, rather than SGLT2 inhibitors. It is not considered a common adverse effect of empagliflozin. C. Gastroparesis: Gastroparesis is a complication of long-standing diabetes due to autonomic neuropathy, not a direct effect of empagliflozin. This drug does not worsen gastric emptying and is not linked to this condition. D. Gastrointestinal disturbances: GI upset, such as nausea or diarrhea, is more commonly linked with metformin or GLP-1 receptor agonists. While possible, it is not the most frequent or concerning side effect of empagliflozin therapy.